DK1146117T3 - En fremgangsmåde til fremstilling af præparationer af modne og umodne endokrine pancreasceller, cellepræparation og anvendelse deraf til behandling af diabetes mellitus - Google Patents

En fremgangsmåde til fremstilling af præparationer af modne og umodne endokrine pancreasceller, cellepræparation og anvendelse deraf til behandling af diabetes mellitus

Info

Publication number
DK1146117T3
DK1146117T3 DK00201326T DK00201326T DK1146117T3 DK 1146117 T3 DK1146117 T3 DK 1146117T3 DK 00201326 T DK00201326 T DK 00201326T DK 00201326 T DK00201326 T DK 00201326T DK 1146117 T3 DK1146117 T3 DK 1146117T3
Authority
DK
Denmark
Prior art keywords
preparing
treatment
diabetes mellitus
matures
mature
Prior art date
Application number
DK00201326T
Other languages
Danish (da)
English (en)
Inventor
Daniel Pipeleers
Original Assignee
Beta Cell N V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beta Cell N V filed Critical Beta Cell N V
Application granted granted Critical
Publication of DK1146117T3 publication Critical patent/DK1146117T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK00201326T 2000-04-12 2000-04-12 En fremgangsmåde til fremstilling af præparationer af modne og umodne endokrine pancreasceller, cellepræparation og anvendelse deraf til behandling af diabetes mellitus DK1146117T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201326A EP1146117B1 (en) 2000-04-12 2000-04-12 A method for producing preparations of mature and immature pancreatic endocrine cells, the cell preparation and its use for treatment of diabetes mellitus
CA2363971A CA2363971C (en) 2000-04-12 2001-11-26 A method for producing preparations of mature and immature pancreatic endocrine cells, the cell preparation and its use for treatment of diabetes mellitus

Publications (1)

Publication Number Publication Date
DK1146117T3 true DK1146117T3 (da) 2008-05-26

Family

ID=32070512

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00201326T DK1146117T3 (da) 2000-04-12 2000-04-12 En fremgangsmåde til fremstilling af præparationer af modne og umodne endokrine pancreasceller, cellepræparation og anvendelse deraf til behandling af diabetes mellitus

Country Status (8)

Country Link
US (1) US6686197B2 (pt)
EP (1) EP1146117B1 (pt)
AT (1) ATE384781T1 (pt)
CA (1) CA2363971C (pt)
DE (1) DE60037876T2 (pt)
DK (1) DK1146117T3 (pt)
ES (1) ES2299417T3 (pt)
PT (1) PT1146117E (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003039489A2 (en) * 2001-11-09 2003-05-15 Artecel Sciences, Inc. Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
US20040005301A1 (en) * 2002-02-12 2004-01-08 Goldman Steven A. Identification and high-yield isolation of human pancreatic islet progenitor and stem cells
ES2330438T3 (es) 2003-06-20 2009-12-10 Vrije Universiteit Brussel Vub Procedimiento de generacion de celulas beta de islotes de langerhans a partir de celulas pancreaticas exocrinas.
JP2014509617A (ja) 2011-03-29 2014-04-21 ベタ−セル エンフェー 治療薬のカプセル化方法、およびその使用
WO2013060893A1 (en) * 2011-10-28 2013-05-02 Centre National De La Recherche Scientifique Process of diagnostic, prognostic and therapeutic monitoring of solid tumors
JP6420323B2 (ja) * 2013-09-19 2018-11-07 ベタ−セル エンフェーＢｅｔａ−Ｃｅｌｌ Ｎｖ 糖尿病の治療方法
KR102323291B1 (ko) 2013-09-24 2021-11-05 기너 라이프 사이언시즈, 인크. 세포 임플란트의 기체 처리를 위한 시스템
MX2019005676A (es) 2016-11-15 2019-09-10 Giner Life Sciences Inc Dispositivo percutáneo de difusión de gases adecuado para su uso con un implante subcutáneo.
JP7199632B2 (ja) 2017-05-04 2023-01-06 ガイナー，インク． 堅牢なインプラント可能なガス送達装置ならびにそれを含む方法、システムおよび装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5050612A (en) * 1989-09-12 1991-09-24 Matsumura Kenneth N Device for computer-assisted monitoring of the body
US5858973A (en) * 1994-02-23 1999-01-12 The General Hospital Corporation Transcription factor and uses therefor
US6110743A (en) * 1995-02-10 2000-08-29 The Regents Of The University Of California Development and use of human pancreatic cell lines

Also Published As

Publication number Publication date
DE60037876D1 (de) 2008-03-13
EP1146117A1 (en) 2001-10-17
EP1146117B1 (en) 2008-01-23
ES2299417T3 (es) 2008-06-01
PT1146117E (pt) 2008-05-06
ATE384781T1 (de) 2008-02-15
DE60037876T2 (de) 2009-01-29
CA2363971C (en) 2011-10-11
CA2363971A1 (en) 2003-05-26
US20020177228A1 (en) 2002-11-28
US6686197B2 (en) 2004-02-03

Similar Documents

Publication Publication Date Title
WO2002040630A3 (en) Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering
BR0311362A (pt) métodos, composições e fatores de crescimento e de diferenciação para produzir células produtoras de insulina
WO2005120090A3 (en) In vitro techniques for use with stem cells
AU8212301A (en) Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells
NO964342L (no) Fremgangsmåter for behandling av sykdom under anvendelse av Sertoli-celler og allografter eller zenografter
DE50210575D1 (de) In-vitro-verfahren zum herstellen einer homologen "gestenteten" tissue engineerten herzklappe
NZ592159A (en) Means and methods for influencing the stability of antibody producing cells
AU2001282123A1 (en) Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells
AU3993495A (en) Process for producing transformed cell
BR0210599A (pt) Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
DK1146117T3 (da) En fremgangsmåde til fremstilling af præparationer af modne og umodne endokrine pancreasceller, cellepræparation og anvendelse deraf til behandling af diabetes mellitus
DK0970701T3 (da) Pellets afledt fra keratinocytter til anvendelse som sårhelingsstoffer
WO2006034319A3 (en) Porcine reproductive and respiratory syndrome isolates and methods of use
WO2002010337A3 (en) Method of cloning porcine animals
WO2005030939A3 (en) Method and composition for regulating expansion of stem cells
WO2002043779A3 (en) Use of acacia gum (arabic gum) to isolate and preserve biological material
TW200721980A (en) Method for producing fermented milk, and fermented milk
IL145674A0 (en) USE OF ERbB RECEPTOR LIGANDS IN TREATING DIABETES
WO2005054447A3 (en) Müller stem cells
WO2008092440A3 (de) Therapeutische zusammensetzung und verwendung einer zellfreien substanz
WO2010068054A3 (ko) 홍조류로부터 저농도의 독성 물질을 가진 바이오알코올 원료의 제조방법 및 이를 이용한 바이오알코올의 제조방법
TW200420530A (en) Novel method for preparing methyl 2-diphenylmethylsulfinylacetate
AU2002241277A1 (en) Functional plant, promoter to be used for producing the functional plant and method of using the same
WO2004030628A3 (en) Adult bone marrow derived stem cells
WO2002022848A3 (en) Compositions comprising mixtures of human cytokines and methods of producing the same